Phylogenetic analysis of the mitochondrial genome indicates significant differences between patients with Alzheimer disease and controls in a French- Canadian founder population

American Journal of Medical Genetics

Volumn 85, Issue 1, 1999, Pages 20-30

  Chagnon, Pierre ^a,b   Gee, Mark ^a   Filion, Mario ^a   Robitaille, Yves ^a   Belouchi, Majid ^a   Gauvreau, Denis ^a  

^a Algene Biotechnologies   (Canada)

^b Algène Biotechnologies   (Canada)

Author keywords

Alzheimer disease; Founder population; Mitochondrial DNA sequence; Phylogenetic analysis

Indexed keywords

DNA; MITOCHONDRIAL DNA;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVITY; FEMALE; FLUORESCENCE; GENE FREQUENCY; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; GENOME; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MITOCHONDRION; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BASE SEQUENCE; CANADA; CASE-CONTROL STUDIES; DNA PRIMERS; DNA, MITOCHONDRIAL; FEMALE; FOUNDER EFFECT; FRANCE; GENOME; HUMANS; MALE; MUTATION; NUCLEIC ACID CONFORMATION; PHYLOGENY; POLYMERASE CHAIN REACTION; RNA, TRANSFER, ALA; RNA, TRANSFER, SER;

EID: 0033516529     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19990702)85:1<20::AID-AJMG6>3.0.CO;2-K     Document Type: Article

References (44)

1. Anderson S, Bankier AT, Barrel BG, de Bruijn MHL, Coulson AR, Drouin J, Eperon IC, Nierlich DP, Roe BA, Sanger F, Schreier PH, Smith AJH, Staden R, Young IG. 1981. Sequence and organization of the human mitochondrial genome. Nature 290:457-465.
2. Brown MD, Shoffner JM, Kim YL, Jun AS, Graham BH, Cabell MF, Gurley DS, Wallace. 1996. Mitochondrial DNA sequence analysis of four Alzheimer's and Parkinson's disease patients. Am J Med Genet 61: 283-289.
3. Brown MD, Torroni A, Reckord CL, Wallace DC. 1995. Phylogenetic analysis of Leber's hereditary optic neuropathy mitochondrial DNA's indicates multiples independent occurrences of the common mutations. Hum Mutat 6:311-325.
4. Brown MD, Voljavec AS, Lett MT, Torroni A, Yang CC, Wallace DC. 1992. Mitochondrial DNA complex I and III mutations associated with Leber's hereditary optic neuropathy. Genetics 130:163-173.
5. Cann RL, Brown WM, Wilson AC. 1984. Polymorphic sites and the mechanism of evolution in human mitochondrial DNA. Genetics 1106:479-499.
6. Capaldi RA. 1990. Structure and function of cytochrome c oxidase. Annu Rev Biochem 59:569-596.
7. Chagnon P, Bétard C, Robitaille Y, Cholette A, Gauvreau D. 1995. Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases. Neuroreport 6:711-715.
8. Chagnon P, Robitaille Y, Gauvreau D. 1996. Brain mitochondrial DNA polymorphism and cytochrome oxidase activity in Alzheimer disease. Alzheimer Research 2:237-242.
9. Edland SD, Silvermann JM, Peskind ER, Tsuang D, Wijsman E, Morris JC. 1996. Increased risk of dementia in mothers of Alzheimer's disease cases: Evidence for maternal inheritance. Neurology 47:254-256.
10. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giufra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M, Hardy J. 1991. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704-706.
11. Horwitz B, Grady CL, Schlageter NL, Duara R, Rapoport SI. 1987. Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease. Brain Res 407:294-306.
12. Houshmand M, Larsson NG, Holme E, Oldfors A, Tulinius MH, Andersen O. 1994. Automatic sequencing of mitochondrial tRNA genes in patients with mitochondrial encephalomyopathy. Biochem Biophys Acta 1226:49-55.
13. Hoyer S. 1991. Abnormalities of glucose metabolism in Alzheimer's disease. Ann NY Acad Sci 640:53-58.
14. Hoyer S, Oesterreich K, Wagner O. 1988. Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type. J Neurol 235:143-148.
15. Hutchin T, Cortopassi G. 1995. A mitochondrial DNA clone is associated with increased risk for Alzheimer disease. Proc Natl Acad Sci USA 92:6892-6895.
16. Johns DR, Neufeld MJ. 1991. Cytochrome b mutations in Leber hereditary optic neuropathy. Biochem Biophys Res Commun 181:1358-1364.
17. Khachaturian ZS. 1985. Diagnosis of Alzheimer's disease. Arch Neurol 59:1097-1105.
18. Kish SJ, Bergeron C, Rajput A, Dozic S, Mastrogiacomo F, Chang LJ, Wilson JM, Distefano LM, Nobrega JN. 1992. Brain cytochrome oxidase in Alzheimer's disease. J Neurochem 59:776-779.
19. Kösel S, Egensperger R, Mehraein P, Graeber MB. 1994. No association of mutations at nucleotide 5460 of mitochondrial NADH dehydrogenase with Alzheimer's disease. Biochem Biophys Res Commun 203:745-749.
20. Kumar S, Tamura K, Nei M. 1993. MEGA: Molecular Evolutionary Genetics Analysis, version 1.0. The Pennsylvania State University, University Park, PA 16802.
21. Levy-Lahad E, Wijsman EM, Nemens E, Anderson L, Goddar KA, Weber JL, Bird TD, Schellenberg GD. 1995. A familial Alzheimer's disease locus on chromosome 1. Science 269:970-973.
22. Lin F, Lin R, Wisniewski HM, Hwang TW, Grundke-Iqbal I, Haely-Louie G, Iqbal K. 1992. Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in Alzheimer's brains. Biochem Biophys Res Commun 182:238-246.
23. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDSADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 34:939-944.
24. Mecocci P, MacGarvey U, Beal F. 1994. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 36:747-751.
25. MITOMAP. 1995. Human Mitochondrial Genome Database. Center for Molecular Medicine Emory University, Atlanta, GA. http.//www.gen.emory.edu/mitomap.html.
26. Moraes CT, Ciacci F, Bonilla E, Jansen C, Hirano M, Rao N, Lovelace LP, Schon EA, DiMauro S. 1993. Two novel pathogenic mitochondrial DNA mutation affecting organelle number and protein synthesis: is tRNALeu(UUR) gene an etiologic hot spot. J Clin Invest 92:2906-2915.
27. Parker WD, Filley CM, Parks JK. 1990. Cytochrome oxidase deficiency in Alzheimer's disease. Neurology 40:1302-1303.
28. Parker WD, Parks JK. 1995. Cytochrome c oxidase in Alzheimer's disease brain: Purification and characterization. Neurology 45:482-486.
29. Parker WD, Parks J, Filley CM, Kleinschmidt-DeMasters BK. 1994. Electron transport chain defects in Alzheimer's brain. Neurology 44:1090-1096.
30. Peterson C, Goldman JE. 1986. Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors. Proc Natl Acad Sci USA 83:2758-2762.
31. Petruzzella V, Chen X, Schon EA. 1992. Is a point mutation in the mitochondrial ND2 gene associated with Alzheimer's disease. Biochem Biophys Res Commun 186:491-497.
32. Rapoport SI, Horwitz B, Grady CL, Haxby JV, DeCarli C, Schapiro MB. 1991. Abnormal brain glucose metabolism in Alzheimer's disease as measured by position emission tomography. Adv Exp Med Biol 291: 231-248.
33. Saunders AM, Strittmatter WJ, Schmechel W, St Georges-Hyslop P, Pericak-Vance MA, Roses AD. 1993. Association of apolipoprotein allele E4 with late-onset Alzheimer's disease. Neurology 43:1467-1472.
34. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Holman K, Tsuda T, Mar L, Foncin JF, Bruni AG, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, Da Silva HAR, Haines JL, Pericak-Vances MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St George-Hyslop PH. 1995. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375:754-760.
35. Shoffner JM, Brown MD, Torroni A, Lott MT, Cabell MF, Mirra SS, Beal F, Yang CC, Gearing M, Salvo R, Watts RL, Juncos JL, Hansen LA, Crain BJ, Fayad M, Reckord CL, Wallace DC. 1993. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 17:171-184.
36. Sternberg D, Danan C, Lombes A, Laforet P, Girodon E, Goossens M, Amselem S. 1998. Exhaustive scanning approach to screen all the mitochondrial tRNA genes for mutations and its application to the investigation of 35 independent patients with mitochondrial disorders. Hum Mol Genet 7:33-42..
37. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. 1993. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90:1977-1981.
38. Suomalainen A. 1997. Mitochondrial DNA and disease. Ann Med 29:235-246.
39. Tiberghien D, Robitaille Y, Laroche-Cholette A, Houde L, Grenon M, Gauvreau D. 1993. Retrospective assessment of relative risks of coronary arteriosclerosis and myocardial infarct in autopsy confirmed dementias of the AD and non-AD types. In Alzheimer's Disease: Advances in Clinical and Basic Research. New York: John Wiley & Sons Ltd, 121-127.
40. Torroni A, Petrozzi M, D'Urbano L, Sellitto D, Zeviani M, Carrara F, Carducci C, Leuzzi V, Carelli V, Barboni P, De Negri A, Scozzari R. 1997. Haplotype and phylogenetic analyses suggest that one European-specific mtDNA background plays a role in the expression of Leber hereditary optic neuropathy by increasing the penetrance of the primary mutations 11778 and 14484. Am J Hum Genet 60:1107-1121.
41. Wallace DC. 1994. Mitochondrial DNA mutations in diseases of energy metabolism. J Bioenerg Biomembr 26:241-250.
42. Wallace DC, Shoffner JM, Trounce I, Brown MD, Ballinger SW, Corral-Debrinski M, Horton T, Jun AS, Lott MT. 1995. Mitochondrial DNA mutations in human degenerative disease and aging. Biochim Biophys Acta 1271:141-151.
43. Wong-Riley MTT. 1989. Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci 12:94-101.
44. Wragg MA, Talbot CJ, Morris JC, Lendon CL, Goate AM. 1995. No association found between Alzheimer's disease and a mitochondrial tRNA glutamine gene variant. Neurosci Lett 201:107-110.